From novel biomarkers, to the potential use of the Zika virus as a tumor treatment, read our round-up of the biggest neuro-oncology news from the last year as we mark World Cancer Day.
The aim of this study was to examine the possible correlation between IGF-I levels in serum in large vestibular schwannomas and its potential neuroprotective effect on the vestibulocochlear nerve.
The present study explores the prognostic survival value of pretreatment health-related quality of life (HRQOL) and changes in HRQOL following whole-brain radiation treatment in patients with brain metastases.
In this case report from CNS Oncology the authors present a rare case of a patient with multiple recurrent brain metastases of pancreatic origin.
Discover prognostic survival value of pretreatment health-related quality of life (HRQOL) and changes in HRQOL following whole-brain radiation treatment in patients with brain metastases in this research article from CNS Oncology.
Discover how combined-modality hypofractionated radiotherapy could become the new standard of care for elderly patients with glioblastoma in this editorial from Future Science OA.
As part of our Spotlight on neuroregeneration, Lauren Pulling (Editor) spoke to Dr Terry Burns about his work in the field.
Researchers have demonstrated that the enzymatic activity of R5 receptor-type protein tyrosine phosphatases is a requisite for the maintenance of stem cell properties and tumorigenicity in glioblastoma cells and could be a promising drug target for treatment.
Researchers have uncovered the role of cellular prion protein (PrPC) in Neurofibromatosis Type 2 (NF2) related tumors, offering hope to neuro-tumor patients.
In a new study published in Scientific Reports, the investigators also reported a higher risk of glioblastoma in Alzheimer’s patients.